Literature DB >> 32739970

Antimicrobial resistance in ICUs: an update in the light of the COVID-19 pandemic.

Rafael Cantón1,2, Desirèe Gijón1,2, Patricia Ruiz-Garbajosa1,2.   

Abstract

PURPOSE OF REVIEW: To describe current antimicrobial resistance in ESKAPE Gram-negative microorganisms and their situation in the ICUs, the implication of the so-called high-risk clones (HiRCs) involved in the spread of antimicrobial resistance as well as relevance of the COVID-19 pandemic in the potential increase of resistance. RECENT
FINDINGS: Extended-spectrum and carbapenemase producing Enterobacterales and multidrug and extensive drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii have increased worldwide. Sequence type (ST)131 Escherichia coli, ST258, ST11, ST10, ST147 and ST307 Klebsiella pneumoniae, ST111, ST175, ST235 and ST244 P. aeruginosa HiRCs are responsible for this increase in the ICUs, and some of them are implicated in the emergence of resistance mechanisms affecting new antimicrobials. A similar situation can be found with European clonal complex 1 and clonal complex 2 of A. baumannii. The high use of antimicrobials during the COVID-19 pandemic, particularly in ICUs, might have a negative influence in future trends of antimicrobial resistance.
SUMMARY: The increase of antimicrobial resistance in ICUs is mainly due to the spread of HiRCs and is exemplified with the ESKAPE Gram-negative microorganisms. The COVID-19 pandemic might have a negative impact in the increase of antimicrobial resistance and should be monitored through specific surveillance studies in ICUs.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32739970     DOI: 10.1097/MCC.0000000000000755

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  27 in total

1.  Long-Term Impact of the COVID-19 Pandemic on In-Hospital Antibiotic Consumption and Antibiotic Resistance: A Time Series Analysis (2015-2021).

Authors:  Marianna Meschiari; Lorenzo Onorato; Erica Bacca; Gabriella Orlando; Marianna Menozzi; Erica Franceschini; Andrea Bedini; Adriana Cervo; Antonella Santoro; Mario Sarti; Claudia Venturelli; Emanuela Biagioni; Irene Coloretti; Stefano Busani; Massimo Girardis; José-María Lòpez-Lozano; Cristina Mussini
Journal:  Antibiotics (Basel)       Date:  2022-06-20

2.  Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID.

Authors:  Jorge Calderón-Parra; Antonio Muiño-Miguez; Alejandro D Bendala-Estrada; Antonio Ramos-Martínez; Elena Muñez-Rubio; Eduardo Fernández Carracedo; Javier Tejada Montes; Manuel Rubio-Rivas; Francisco Arnalich-Fernandez; Jose Luis Beato Pérez; Jose Miguel García Bruñén; Esther Del Corral Beamonte; Paula Maria Pesqueira Fontan; Maria Del Mar Carmona; Rosa Fernández-Madera Martínez; Andrés González García; Cristina Salazar Mosteiro; Carlota Tuñón de Almeida; Julio González Moraleja; Francesco Deodati; María Dolores Martín Escalante; María Luisa Asensio Tomás; Ricardo Gómez Huelgas; José Manuel Casas Rojo; Jesús Millán Núñez-Cortés
Journal:  PLoS One       Date:  2021-05-11       Impact factor: 3.240

3.  Impact of COVID-19 on Antimicrobial Consumption and Spread of Multidrug-Resistance in Bacterial Infections.

Authors:  Kibum Jeon; Seri Jeong; Nuri Lee; Min-Jeong Park; Wonkeun Song; Han-Sung Kim; Hyun Soo Kim; Jae-Seok Kim
Journal:  Antibiotics (Basel)       Date:  2022-04-18

4.  Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance?

Authors:  Dominique L Monnet; Stephan Harbarth
Journal:  Euro Surveill       Date:  2020-11

Review 5.  [Current microbiological aspects of community respiratory infection beyond COVID-19].

Authors:  R Cantón
Journal:  Rev Esp Quimioter       Date:  2021-03-22       Impact factor: 1.553

6.  Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance.

Authors:  Jesús Rodríguez-Baño; Gian Maria Rossolini; Constance Schultsz; Evelina Tacconelli; Srinivas Murthy; Norio Ohmagari; Alison Holmes; Till Bachmann; Herman Goossens; Rafael Canton; Adam P Roberts; Birgitta Henriques-Normark; Cornelius J Clancy; Benedikt Huttner; Patriq Fagerstedt; Shawon Lahiri; Charu Kaushic; Steven J Hoffman; Margo Warren; Ghada Zoubiane; Sabiha Essack; Ramanan Laxminarayan; Laura Plant
Journal:  Trans R Soc Trop Med Hyg       Date:  2021-10-01       Impact factor: 2.184

Review 7.  Virus-Induced Changes of the Respiratory Tract Environment Promote Secondary Infections With Streptococcus pneumoniae.

Authors:  Vicky Sender; Karina Hentrich; Birgitta Henriques-Normark
Journal:  Front Cell Infect Microbiol       Date:  2021-03-22       Impact factor: 5.293

Review 8.  COVID-19: Impact on prescribing and antimicrobial resistance.

Authors:  P Ruiz-Garbajosa; R Cantón
Journal:  Rev Esp Quimioter       Date:  2021-09-30       Impact factor: 1.553

Review 9.  Implications of COVID-19 Pandemic on the Emergence of Antimicrobial Resistance: Adjusting the Response to Future Outbreaks.

Authors:  Doris Rusic; Marino Vilovic; Josipa Bukic; Dario Leskur; Ana Seselja Perisin; Marko Kumric; Dinko Martinovic; Ana Petric; Darko Modun; Josko Bozic
Journal:  Life (Basel)       Date:  2021-03-10

10.  Impact of coronavirus disease 2019 on infectious disease treatment and infection control at a tertiary hospital in Japan.

Authors:  Waki Imoto; Koichi Yamada; Gaku Kuwabara; Wataru Shibata; Norihiro Sakurai; Yuka Nonose; Yasuyo Okada; Kiyotaka Nakaie; Akiko Fujita; Hiroshi Kakeya
Journal:  J Infect Chemother       Date:  2022-01-26       Impact factor: 2.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.